Cora King
Primary Care · Raeford, NCNPI 1023654068
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 284 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by AstraZeneca at 27.5% of the total. Reporting peaked in 2021 at $3,010 and has fallen 82.8% since, to $517 in 2024. Among primary care clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 284 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$884
- GSK$457
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$275
- Boehringer Ingelheim$269
- Sanofi-aventis U.S. LLC$206
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,260100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 48 | $1,445 |
| Novo Nordisk | 60 | $884 |
| GSK | 35 | $457 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $275 |
| Boehringer Ingelheim | 15 | $269 |
| Sanofi-aventis U.S. LLC | 12 | $206 |
| Lilly USA, LLC | 18 | $204 |
| Bayer | 9 | $146 |
| Biohaven Pharmaceuticals, Inc. | 3 | $145 |
| Amgen | 12 | $144 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $120 |
| AbbVie | 6 | $113 |
| Nestle Healthcare Nutrition Inc. | 5 | $104 |
| Esperion Therapeutics, Inc. | 5 | $101 |
| Johnson & Johnson | 6 | $84 |
| Amarin Pharma, Inc. | 4 | $71 |
| Ironwood Pharmaceuticals, Inc | 4 | $66 |
| Pfizer | 4 | $66 |
| Scilex Pharmaceuticals Inc. | 3 | $61 |
| Medtronic | 2 | $49 |
| Eisai Inc. | 3 | $44 |
| Exact Sciences | 2 | $37 |
| Sunovion Pharmaceuticals Inc. | 2 | $25 |
| Mylan Specialty L.p. | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Eyevance Pharmaceuticals LLC | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Merck | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Corcept Therapeutics | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,260 in reported general payments places this provider in the 90th percentile of 236 primary care providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 15 | $15,516 |
| EliquisApixaban | 11 | $8,365 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $732 |
| Gabapentin | 32 | $551 |
| Omeprazole | 15 | $361 |
| Atorvastatin Calcium | 45 | $209 |
| Cyclobenzaprine Hcl | 21 | $176 |
| Lisinopril | 41 | $168 |
| Amlodipine Besylate | 42 | $165 |
| Montelukast Sodium | 18 | $147 |
| Hydroxyzine Hcl | 11 | $135 |
| Levothyroxine Sodium | 32 | $132 |
| Metformin Hcl | 24 | $95 |
| Pantoprazole Sodium | 23 | $89 |
| Hydrochlorothiazide | 19 | $78 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $1,445 | $15,51615 claims |
| PfizerEliquis | $66 | $8,36511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 236 primary care providers in North Carolina.
Other primary care in Raeford
- Priscilla LocklearRaeford$2K
- Jessica AllynRaleigh$21K
- Jennifer RogersWinston Salem$17K
- Elizabeth WaltersChapel Hill$14K
- Ragan JohnsonChapel Hill$13K
- Kirkland DickeyPine Hall$11K
- Kimberly WeaverHickory$9K
- Amanda StoneWilmington$9K
- Elizabeth WalshGreensboro$7K
- Mark HollingsworthWilmington$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.